KRISTINA JAMES: Open Payments
NPI 1912452061 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,095 in 131 payments from 27 companies in 2025. Trend: 2023 $3,382 · 2024 $3,771 · 2025 $3,095
Food & beverage: $3,095
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $455 |
| ABBVIE INC. | 22 | $366 |
| UCB, Inc. | 9 | $317 |
| Celgene Corporation | 7 | $208 |
| Eisai Inc. | 6 | $152 |
| Genentech USA, Inc. | 6 | $132 |
| Janssen Biotech, Inc. | 5 | $125 |
| Lundbeck LLC | 5 | $120 |
| Neurocrine BioSciences, Inc. | 3 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
Products named: NURTEC ODT, ZEPOSIA, Leqembi, QULIPTA, Ocrevus Zunovo, Rystiggo, INGREZZA, KESIMPTA.
Industry payments across GA — which companies pay providers there.
